Healthcare & Deep Tech Fund

Investing in the Future of Healthcare & Deep Tech

Lumina Ventures Fund I is a $4.5M fund backing four transformative AI ventures addressing critical challenges in maternal health, surgical safety, clinical workflow, and infrastructure intelligence.

$4.5M
Fund Size
4
Portfolio Companies
$280B+
Combined TAM
Portfolio Companies

Four Ventures, One Vision

Each company addresses a critical gap in healthcare or infrastructure with breakthrough technology, validated through the LAHI Live 2026 innovation competition.

LAHI Winner

Materna Health

Digital Mommy Passport

Patient-owned maternal health records that follow mothers across providers. 84% of maternal deaths are preventable with better data continuity.

$750K
Pre-Seed
$110B
TAM
5,000+
LOI Pregnancies
Runner-Up

ParkSense AI

Edge AI Spatial Intelligence

Zero-latency computer vision for parking and security. On-device AI processing with 99% detection accuracy. Live deployments active.

$1.5M
Seed
$121B
TAM
99%
Accuracy

NeuraSense Labs

Surgical AI Safety Platform

Bioimpedance-guided nerve detection for robotic surgery. 44% of surgical nerve injuries go unrecognized. Building the brain of next-gen surgical robots.

$1.5M
Seed
$9.5B
TAM
70%
Target Margins

Sigma HealthSense

Clinical Evidence OS

AI-powered workflow automation for imaging clinics. Converts 7-day report cycles to 24 hours. Live pilot at New Hope Life Scan, Brea.

$750K
Seed
$40B
TAM
85%
Automation
Leadership & Advisors

World-Class Expertise

Our team and advisors bring experience from leading institutions in healthcare, deep tech, and finance.

Stanford Harvard UCLA USC Cedars-Sinai Novo Nordisk Mount Sinai Brigham & Women's Harvard Chan UCSD Lund University Karolinska

Our team and advisors have experience from Stanford, Harvard Medical School, UCLA, USC, UCSD, Cedars-Sinai, Brigham & Women's, Mount Sinai, Novo Nordisk, Lund University, and Karolinska Institute.

Ready to Learn More?

Access comprehensive pitch decks, video presentations, and financial projections for our portfolio companies.

Access Investor Portal Contact IR Team